Cite Filings / AMLX / 0000902664-25-002243

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Amylyx Pharmaceuticals, Inc. Filed 2025-05-12 Acc 0000902664-25-002243

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-06-25 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-12 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-08 10-Q Quarterly Report
2025-05-08 8-K Results of operations
2025-01-14 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…